Venkys (India) LtdQ3 FY23Food Products

Venkys (India) Ltd

Q3 FY23 Earnings Call Analysis

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Order

N/A

Capex

Yes

1 of 4 growth signals are positive — mixed outlook.

Revenue guidance

Category 3

→Venky's expects continuous growth of approximately 10% in revenues, particularly from QSR (Quick Service Restaurant) sector expansion in India.
→QSRs are growing steadily post-COVID, with an emphasis on chicken menu items, driving demand.
→Venky’s serves QSRs pan-India for frozen chicken products; chilled chicken supplies are regional.
→New animal health plant coming online by year-end will add 15-20% volume growth in that segment.
→Overall poultry segment volume expected to be strong with traditional consumption upticks in Q3 and Q4.
→Oilseed segment volume likely to maintain previous year’s levels but no significant growth due to edible oil price pressures.
→Feed capacity utilization currently moderate, indicating potential for increased production without large capex.
→Venky's plans to introduce new fast-food products in its outlets to drive expansion and growth.

Category 3

→Venky's expects continuous growth of approximately 10% annually from QSR (Quick Service Restaurants) sector sales, driven by expanding QSR business activities and menu items, particularly in chicken products.
→The poultry segment is anticipated to see strong volume growth going ahead, with profitability expected to improve in Q3 and Q4 due to traditional consumption patterns.
→Animal Health Products (AHP) segment will benefit from a new plant starting production by end of FY'24, expected to boost top-line revenue by around 15-20%.
→Margins in oilseed and edible oil segments may remain under pressure till after elections (May), but the company aims to sustain volume at last year's level.
→Feed price stability and improved production efficiency (feed conversion ratio improved from 1.7 to 1.5) support margin improvement.
→Overall, growth in revenue, operating earnings, and profits is expected to be supported by increasing QSR demand, expanded capacity, and introduction of new products.

Get access to all 5 sections — revenue, margin, fundraise, orderbook, and capex — for Venkys (India) Ltd and 1,400+ other companies.

→No major new debt or equity fundraising planned in the next 2-3 years.
→Existing term loans for animal health product division and SPF project have been fully paid off.
→Current borrowings (~INR 170 crores) primarily consist of working capital limits, which are expected to remain stable and not reduce significantly.
→Capital expenditures are minimal, mostly normal capitalization (~INR 40-50 crores) for existing poultry units, funded through internal accruals.
→New animal health care project (cost ~INR 67 crores) capitalization is already completed using internal accruals, no external borrowing.
→Overall, ample capacity utilization and no immediate plans for raising funds through debt or equity.

→The transcript does not explicitly mention specific details about the current or expected orderbook or pending orders for Venky's.
→However, the management indicated that they have sufficient volumes planned and packed production for the remaining part of the current and next quarter, implying a healthy order pipeline.
→For the poultry segment, volumes are expected to be strong going forward.
→In the QSR segment, Venky's is actively supplying frozen chicken pan-India, indicating ongoing and potential orders across regions.
→New product introductions in the fast food chain segment (Venky's Express and franchises) are expected soon, signaling anticipated growth in orders.
→The new animal health product plant coming online is expected to boost revenue by around 15%-18%, reflecting expected incremental orders.
→Overall, capacity utilization suggests ample capacity to cater to future demand without immediate constraints.

Yes

→No major capex projects planned in the next 2-3 years; ample existing capacity across segments (poultry, feed mill, AHP, oilseed) to cater to demand.
→New animal health care plant project (~INR 67 crores) is near completion with production expected to start in the last quarter of FY24 (December 2023).
→This new plant will ensure regulatory compliance and add 15-18% additional volume in the animal health segment next financial year.
→Capitalization for the new AHP project is complete and funded through internal accruals; only regulatory clearance pending.
→Normal annual capitalization of INR 40-50 crores expected for maintenance/upkeep of existing poultry units, funded internally.
→No significant external debt planned; current borrowings mainly working capital which will remain stable.

How does Venkys (India) Ltd rank vs peers in Food Products?

Pro feature

1Venkys (India) Ltd

Rev 3Mar 3

See full Food Products sector rankings

Want more stocks like Venkys (India) Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.